A Cellulose-Binding Domain-Fused Recombinant Human
T Cell Connective Tissue-Activating Peptide-III
Manifests Heparanase Activity
Meirav Rechter,* Ofer Lider,*
,1
Liora Cahalon,* Ehud Baharav,* Mara Dekel,† Daniel Seigel,†
Israel Vlodavsky,‡ Helena Aingorn,‡ Irun R. Cohen,* and Oded Shoseyov†
*Department of Immunology, The Weizmann Institute of Science, Rehovot 76100, Israel; †Kennedy Leigh Centre
for Horticultural Research and the Otto Warburg Center for Agricultural Biotechnology,
The Faculty of Agriculture, The Hebrew University of Jerusalem, Rehovot, Israel; and
‡Department of Oncology, Hadassah-Hebrew University Hospital, Jerusalem, Israel
Received December 29, 1998
The chemokine connective tissue-activating peptide
(CTAP)-III, which belongs to the leukocyte-derived
growth factor family of mediators, was previously
shown to be mitogenic for fibroblasts. However, it has
recently been shown that CTAP-III, released from
platelets, can act like a heparanase enzyme and de-
grade heparan sulfate. This suggests that CTAP-III
may also function as a proinflammatory mediator. We
have successfully cloned CTAP-III from a gt11 cDNA
library of PHA-activated human CD4
T cells and pro-
duced recombinant CTAP-III as a fusion protein with
a cellulose-binding domain moiety. This recombinant
CTAP-III exhibited heparanase activity and released
degradation products from metabolically labeled, nat-
urally produced extracellular matrix. We have also
developed polyclonal and monoclonal antibodies, and
these antibodies against the recombinant CTAP-III de-
tected the CTAP-III molecule in human T cells, poly-
morphonuclear leukocytes, and placental extracts.
Thus, our study provides tools to examine further im-
mune cell behavior in inflamed sites rich with extra-
cellular moieties and proinflammatory mediators.
© 1999 Academic Press
Chemokines are a recently characterized family of
pro-inflammatory mediators that function biologically
in both blood vessels and in extracellular matrix sites
to promote immune cell-adhesion and migration (1-4).
One member of the C-X-C chemokine sub-family, con-
nective tissue-activating peptide (CTAP)-III, is mito-
genic for connective tissue cells, stimulates glucose
uptake, glycosaminoglycan synthesis, proliferation of
fibroblasts and synovial cells (5,6), induces the release
of histamine from basophils (7), and induces plasmin-
ogen activator activity (8). Detection of CTAP-III in
wound fluid (9), in the synovium in osteoarthritis, and
in the sera of rheumatoid arthritis patients (10,11)
suggests that CTAP-III may also be involved in inflam-
mation. CTAP-III is a N'-truncated derivative of the
leukocyte-derived growth factor (LDGF) molecule
(12,13). Cleavage of LDGF (a 128-amino acid protein)
at its Arg-Asn site generates CTAP-III, a 85-amino
acid protein with a molecular weight of 9278 Da (13).
CTAP-III has been identified in platelets (6), activated
macrophages, neutrophils, and more recently, also in T
lymphocytes (12), all of which are involved in inflam-
matory reactions.
In addition to the stimulatory activities of CTAP-III,
heparanase-like heparan sulfate-degrading activity of
platelet-derived CTAP-III has been recently reported
(14). Specifically, a heparan sulfate-degrading mole-
cule was purified from human platelets. N-terminal
sequencing revealed that this enzymatic activity was
due mainly to CTAP-III and neutrophil-activating pep-
tide (NAP)-2, and partially to platelet basic protein
(PBP), all of which are derivatives of the LDGF gene.
This heparanase activity is also present in commer-
cially prepared CTAP-III isolated from human plate-
lets (14), but not in commercially prepared recombi-
nant NAP-2.
Heparan sulfate proteoglycans (HSPG) are associ-
ated with cell surfaces and the extracellular matrix
(ECM; 15) and bind growth factors and cytokines.
Cleavage of the heparan sulfate moieties of HSPG in
1
To whom correspondence should be addressed at Department of
Immunology, The Weizmann Institute of Science, Rehovot 76100, Is-
rael. Fax: 792-8-9343657. E-mail: lclider@weizmann.weizmann.ac.il.
Abbreviations used: CTAP-III, connective tissue activating pep-
tide-III; LDGF, leukocyte derived growth factor; NAP-2, neutrophil
activating peptide-2; HSPG, heparan sulfate proteoglycans; ECM,
extracellular matrix; CBD, cellulose binding domain.
Biochemical and Biophysical Research Communications 255, 657– 662 (1999)
Article ID bbrc.1999.0181, available online at http://www.idealibrary.com on
657 0006-291X/99 $30.00
Copyright © 1999 by Academic Press
All rights of reproduction in any form reserved.